AbbVie to Host First-Quarter 2018 Earnings Conference Call
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Strong earthquake rocks north-central Venezuela, capital Caracas
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
Abbvie (ABBV) CL 'Buy' Rating Reiterated at Goldman Sachs Following Management Meetings; 'Sell-Off Misaligned with Fundamentals'
April 6, 2018 9:00 AM EDTGoldman Sachs maintained its price target on Abbvie (NYSE: ABBV) at $135.00 while maintaining a Conviction Buy rating, following meetings with management.
Analyst Jami Rubin reiterates the outlook and price target on the shares, despite the recent sell-off in shares (down 19.51% over the... More
